市場調查報告書
商品編碼
1486832
卵圓孔未閉 (PFO) 封堵器的全球市場 - 市場分析、競爭格局、市場預測 (2030)Patent Foramen Ovale (PFO) Closure Devices - Market Insights, Competitive Landscape and Market Forecast-2030 |
預計 2024 年至 2030 年預測期內,全球卵圓孔未閉 (PFO) 封堵器市場規模將以 5.46% 的複合年增長率成長。卵圓孔未閉(PFO)封堵器的需求主要是由於老年人口的增加和腦梗塞盛行率的增加而增加。此外,技術進步的不斷進步促使全球新產品的開發和推出也是推動 2024-2030 年預測期內市場成長的主要因素。
卵圓孔未閉(PFO)封堵器的市場動態
根據世界衛生組織(WHO)2022年發佈的數據,到2030年,全球六分之一的人將年齡在60歲或以上。此外,根據相同數據,60歲及以上的人口將從2020年的10億增加到2050年的14億。
根據聯合國人口司的數據,到2050年,德國65歲及以上的人口預計將增加41%,達到2,400萬,佔總人口的近三分之一。隨著年齡的增長,心臟會經歷各種結構/功能變化,這是正常老化過程的一部分。這些變化會影響心血管系統,並可能導致卵圓孔未閉 (PFO) 的持續存在和發展。
因此,老年人口的增加預計將對卵圓孔未閉 (PFO) 封堵器市場的成長產生正面影響。
根據美國中風協會 (2021) 的數據,大約三分之一 (35%) 的缺血性中風被歸類為隱性中風。此外,所有不明原因的中風有一半是栓塞性中風。因此,中風盛行率的上升產生了預防中風復發的需求,從而推動了卵圓孔未閉(PFO)封堵器市場的成長。
然而,有關設備併發症和長期安全性的擔憂、與卵圓孔未閉 (PFO) 閉合設備和手術相關的高成本等,可能會限制市場成長。
卵圓孔(PFO)封堵器細分市場分析
在卵圓孔未閉(PFO) 封堵器市場的產品類型細分中,Amplatzer PFO 封堵器類別預計將在2023 年佔據卵圓孔未閉(PFO) 封堵器市場的重要收入佔有率。這是由於 Amplatzer PFO 封堵器設備提供的各種優勢。該裝置用於治療與 PFO 相關的某些醫療狀況,例如隱匿性中風和復發性偏頭痛。 Amplatzer PFO 封堵器提供的主要優點之一是 Amplatzer PFO 封堵器的插入通常使用微創手術(例如經導管封堵器)進行。這種方法避免了心臟直視手術的需要,從而縮短了恢復時間並減少了術後併發症。此外,該裝置的設計目的是有效地閉合卵圓孔,防止血栓和其他物質在心室之間通過,從而降低異常栓塞的風險,異常栓塞是馬甦的潛在原因。因此,Amplatzer PFO 封堵器提供的各種優勢預計將有助於該細分市場的成長。
此外,隨著該細分市場需求的增長,市場公司向市場推出了各種新產品。例如,2022年9月,雅培在歐洲市場推出Amplatzer(TM) Talisman(TM) PFO封堵系統,用於治療卵圓孔未閉(PFO)患者。
因此,由於上述因素,Amplatzer PFO 封堵器預計將出現顯著增長,從而推動整個卵圓孔未閉 (PFO) 封堵器市場在預測期內的增長。北美預計將主導整個卵圓孔未閉 (PFO) 封堵器市場
預計到 2023 年,北美將在所有地區中佔據卵圓孔未閉 (PFO) 封堵器市場的最高佔有率。這是由於該地區中風發病率不斷增加。此外,技術進步、關鍵參與者的存在、老年人口的增加以及產品開發、上市和批准方面的高前景正在推動北美卵圓孔未閉(PFO)封堵器市場的成長。
本報告研究和分析了全球卵圓孔未閉 (PFO) 封堵器市場,提供市場規模和預測、驅動因素和課題、公司和產品概況等。
Patent Foramen Ovale Closure Device Market By Product Type (Amplatzer Pfo Occluder, Cardioform Septal Occluder, And Others), End-User (Hospitals And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of cryptogenic stroke and increasing technological advancement leading to new product development
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The demand for Patent Foramen Ovale Closure device is primarily being bolstered by the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development and launches across the globe, is another major factor that is contributing to the growth of the Patent Foramen Ovale Closure market during the forecast period from 2024-2030.
Patent Foramen Ovale Closure Device Market Dynamics:
As per the data provided by the World Health Organization 2022, by the year 2030, 1 in 6 people in the world will be aged 60 years or over. Further, according to the same source the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion and by 2050.
According to the UN Population Division, Germany's population aged 65 and older is projected to grow by 41 percent to 24 million by 2050, accounting for nearly one-third of the total population. As the age increases the heart undergoes various structural and functional changes as a part of the normal aging process. These changes can affect the cardiovascular system, potentially contributing to the persistence or development of a Patent Foramen Ovale.
Therefore, the rise in the geriatric population will positively influence the growth of the Patent Foramen Ovale (PFO) Closure Devices market.
According to the data provided by the American Stroke Association 2021, around one in three which accounts for (35%) ischemic strokes are classified as cryptogenic. Additionally, half of the cryptogenic strokes are embolic strokes, which have an unknown origin. Thus, the rising incidence of cryptogenic strokes will create a need for the prevention of recurrent cryptogenic strokes thus eventually boosting the growth of the Patent Foramen Ovale Closure Device market.
However, the complications and concerns associated with the long-term safety of the device and the high cost associated with the Patent Foreman Ovale Closure Devices and procedures are some of the key constraints that may limit the growth of the Patent Foramen Ovale Closure Device market.
Patent Foramen Ovale Closure Device Market Segment Analysis:
Patent Foramen Ovale Closure Device Market by product type (Amplatzer PFO Occluder, Cardioform Septal Occluder, and Others), End-users (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Patent Foramen Ovale Closure Device market, the Amplatzer PFO Occluder category is estimated to amass a significant revenue share in the Patent Foramen Ovale Closure Device Market in 2023. This can be attributed to the various advantages provided by Amplatzer PFO Occluder devices. The device is used for the treatment of certain medical conditions associated with PFO, such as cryptogenic strokes and recurrent migraines. One of the major advantages provided by Amplatzer PFO Occluder devices is that the insertion of the Amplatzer PFO Occluder is typically performed using a minimally invasive procedure, such as transcatheter closure. This approach avoids the need for open-heart surgery, leading to shorter recovery times and reduced postoperative complications. Additionally, the device is designed to effectively close the PFO, preventing the passage of blood clots or other materials between the heart chambers, thus reducing the risk of paradoxical embolism, which is a potential cause of cryptogenic strokes. Therefore, the various advantages provided by the Amplatzer PFO Occluder device is expected to contribute to the growth of the segment.
Furthermore, as the demand for this segment grows, various novel products are launched by market players in the market. For example, in September 2022, Abbott launched its Amplatzer(TM) Talisman(TM) PFO Occlusion System in the European market for the treatment of patients suffering from patent foramen ovale (PFO).
Therefore, owing to the above-mentioned factors, the Amplatzer PFO Occluder is expected to register significant growth, thereby driving the growth of the overall Patent Foramen Ovale Closure Device market during the forecast period.
North America Is Expected To Dominate The Overall Patent Foramen Ovale Closure Device Market:
North America is expected to account for the highest proportion of the Patent Foramen Ovale Closure Device Market in 2023, out of all regions. This is due to the increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, the presence of major players, increasing geriatric population, and a highly potent market in terms of product development, launches, and approvals are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.
According to the data provided by the American College of Cardiology 2019, it was estimated that cryptogenic strokes accounted for 15-40% of all strokes. Additionally, approximately 795,000 individuals suffer from cryptogenic strokes every year in the United States. Thus, the rising incidence of cryptogenic strokes will create a need for the treatment and management of Patent Foramen Ovale, thus resulting in the positive growth of the Patent Foramen Ovale Closure Device Market in the United States, which will eventually propel the Patent Foramen Ovale Closure Device market in North America.
Further, key players present in the region, such as, Abbott, W. L. Gore & Associates, Inc., and Occlutech Holding AG are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.
Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for Patent Foramen Ovale Closure Devices in North America during the forecast period.
Patent Foramen Ovale Closure Device Market Key Players:
Some of the key market players operating in the Patent Foramen Ovale Closure Device market include Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
Recent Developmental Activities In The Patent Foramen Ovale Closure Device Market:
Key Takeaways From The Patent Foramen Ovale Closure Device Market Report Study
Target Audience Who Can Be Benefited From This Patent Foramen Ovale Closure Device Market Report Study
Frequently Asked Questions For The Patent Foramen Ovale Closure Device Market:
A Patent Foramen Ovale Closure Device is a medical device used to close a small hole called a foramen Ovale present between the upper two heart chambers (atria) in patients suffering from patent foramen Ovale.
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.
The Patent Foramen Ovale Closure Device Market is slated to witness prosperity owing to factors such as the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development across the globe, are some of the other factors resulting in appreciable revenue growth in the Patent Foramen Ovale Closure Device Market during the forecast period (2024-2030).
Some of the key market players operating in the Patent Foramen Ovale Closure Device Market Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
North America is expected to dominate the overall Patent Foramen Ovale Closure Device Market during the forecast period, 2024 to 2030. This can be ascribed to the presence of developed and sophisticated healthcare infrastructure, rising aging population, and increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, presence of major players, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.